Search results for: Cancer
Filter search results
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…which evaluated the current burden of cancer and identified opportunities for increased efficiency in cancer care. The evidence focused specifically on the health and cancer care landscape in nine European…
Value and Cancer: Journal of Cancer Policy Special Issue
25 January 2017
A special issue of the Journal of Cancer Policy entitled ‘Value and Cancer’ includes three papers authored by OHE researchers. Professor Bengt Jönsson, a member of OHE’s Research and Policy…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
Making Outcome-based payments a reality in the NHS authored by The Office of Health Economics, RAND Europe, King’s College London, and Cancer Research UK, and commissioned by Cancer Research UK…
The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?
24 January 2024
…lifetime cost of cervical cancer is approximately £210,000 per case. The total preventable burden of cervical cancer in the UK is £406 million – based on the difference between socioeconomic…
Cancer Survivorship Burden
6 March 2018
…Margherita Neri will be published in a special issue of the Journal of Cancer Policy. The issue focuses on cancer survivors and cancer survivorship and our article (available as open…
Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
3 July 2018
…different cancers, with the majority collecting data from over 100 LTCS. LTCS included in the studies were more likely to have experienced early-stage cancer relative to late-stage cancer. Of the…
Government and Charity Funding of Cancer Research: Public Preferences and Choices
13 October 2015
…of cancer appears to be a more important driver of people’s decisions to donate to cancer research charities. If the government were to cut funding for cancer research, it seems…
Lung Cancer’s Biggest Test: How Can We Mobilise NGS Testing to Transform Lung Cancer Care?
7 December 2023, 12:00am
…The gaps in funding and implementation are a significant barrier for patients with lung cancer benefitting from the use of NGS testing and the advanced precision treatments it facilitates. In…
OHE Lunchtime Seminar: How Cost-Effective are New Cancer Drugs in the U.S.?
18 September 2017, 11:00pm
OHE Lunchtime Seminar with Professor Frank Lichtenberg, Columbia University. The number of drugs approved by the FDA for treating cancer has increased substantially during the last 40 years. Moreover, cancer…